NRBO Shares Outstanding History



Below is a table of the NRBO shares outstanding history going back to 12/31/2019:

Date NRBO Shares Outstanding
12/31/20192479
3/23/202065322
5/14/202068447
8/11/202068447
11/6/202068447
4/9/202192380
5/12/202192380
8/12/202192856
3/25/2022111091
5/11/2022111091
8/11/2022111091
11/11/2022812941
3/24/20233.40M
5/11/20233.41M
8/4/20234.80M
11/9/20234.85M

Also see: NRBO Market Cap History
NRBO YTD Return
NRBO Historical Shares Outstanding:
+612.34% CAGR
NRBO Historical Shares Outstanding: +612.34% CAGR

Mouse over chart for data details
12/31/2019 ...11/9/2023
NeuroBo Pharmaceuticals is a clinical-stage biotechnology company focused primarily on developing and commercializing pharmaceuticals to treat cardiometabolic diseases. Co. has two primary programs focused on treatment of nonalcoholic steatohepatitis (NASH), obesity and type 2 diabetes (T2D): DA-1241, which is a G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; as well as DA-1726, which is an oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity that is to be administered once weekly subcutaneously. We show 16 historical shares outstanding datapoints in our coverage of NRBO's shares outstanding history.

Understanding the changing numbers of NRBO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NRBO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NRBO by allowing them to research NRBO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree NRBO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NeuroBo Pharmaceuticals (NRBO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NRC Shares Outstanding History
NRIX Shares Outstanding History
NSPR Shares Outstanding History
NSTG Shares Outstanding History
NTEC Shares Outstanding History
NTGN Shares Outstanding History
NTLA Shares Outstanding History
NTRA Shares Outstanding History
NTRB Shares Outstanding History
NTUS Shares Outstanding History
More Healthcare companies »

 

NRBO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.